Literature DB >> 30003866

Antimicrobial Resistance in Escherichia coli.

Laurent Poirel1,2,3, Jean-Yves Madec4, Agnese Lupo4, Anne-Kathrin Schink5, Nicolas Kieffer1, Patrice Nordmann1,2,3, Stefan Schwarz5.   

Abstract

Multidrug resistance in Escherichia coli has become a worrying issue that is increasingly observed in human but also in veterinary medicine worldwide. E. coli is intrinsically susceptible to almost all clinically relevant antimicrobial agents, but this bacterial species has a great capacity to accumulate resistance genes, mostly through horizontal gene transfer. The most problematic mechanisms in E. coli correspond to the acquisition of genes coding for extended-spectrum β-lactamases (conferring resistance to broad-spectrum cephalosporins), carbapenemases (conferring resistance to carbapenems), 16S rRNA methylases (conferring pan-resistance to aminoglycosides), plasmid-mediated quinolone resistance (PMQR) genes (conferring resistance to [fluoro]quinolones), and mcr genes (conferring resistance to polymyxins). Although the spread of carbapenemase genes has been mainly recognized in the human sector but poorly recognized in animals, colistin resistance in E. coli seems rather to be related to the use of colistin in veterinary medicine on a global scale. For the other resistance traits, their cross-transfer between the human and animal sectors still remains controversial even though genomic investigations indicate that extended-spectrum β-lactamase producers encountered in animals are distinct from those affecting humans. In addition, E. coli of animal origin often also show resistances to other-mostly older-antimicrobial agents, including tetracyclines, phenicols, sulfonamides, trimethoprim, and fosfomycin. Plasmids, especially multiresistance plasmids, but also other mobile genetic elements, such as transposons and gene cassettes in class 1 and class 2 integrons, seem to play a major role in the dissemination of resistance genes. Of note, coselection and persistence of resistances to critically important antimicrobial agents in human medicine also occurs through the massive use of antimicrobial agents in veterinary medicine, such as tetracyclines or sulfonamides, as long as all those determinants are located on the same genetic elements.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30003866     DOI: 10.1128/microbiolspec.ARBA-0026-2017

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  99 in total

1.  A ProQ/FinO family protein involved in plasmid copy number control favours fitness of bacteria carrying mcr-1-bearing IncI2 plasmids.

Authors:  Jun Yang; Hai-Hong Wang; Yaoyao Lu; Ling-Xian Yi; Yinyue Deng; Luchao Lv; Vincent Burrus; Jian-Hua Liu
Journal:  Nucleic Acids Res       Date:  2021-04-19       Impact factor: 16.971

2.  Multiple Copies of qnrA1 on an IncA/C2 Plasmid Explain Enhanced Quinolone Resistance in an Escherichia coli Mutant.

Authors:  Laura Vinué; Mohamad R A Sater; Ian Herriott; Miriam H Huntley; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  mcr-9, an Inducible Gene Encoding an Acquired Phosphoethanolamine Transferase in Escherichia coli, and Its Origin.

Authors:  Nicolas Kieffer; Guilhem Royer; Jean-Winoc Decousser; Anne-Sophie Bourrel; Mattia Palmieri; Jose-Manuel Ortiz De La Rosa; Hervé Jacquier; Erick Denamur; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

4.  A MoS2 based silver-doped ZnO nanocomposite and its antibacterial activity against β-lactamase expressing Escherichia coli.

Authors:  Atanu Naskar; Joonho Shin; Kwang-Sun Kim
Journal:  RSC Adv       Date:  2022-03-02       Impact factor: 3.361

5.  Escherichia coli Sequence Type 457 Is an Emerging Extended-Spectrum-β-Lactam-Resistant Lineage with Reservoirs in Wildlife and Food-Producing Animals.

Authors:  Steven P Djordjevic; Monika Dolejska; Kristina Nesporova; Ethan R Wyrsch; Adam Valcek; Ibrahim Bitar; Khin Chaw; Patrick Harris; Jaroslav Hrabak; Ivan Literak
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

6.  Immunostimulatory Activities of Coliphages on In Vitro Activated Mammalian Macrophages.

Authors:  Gizem Yıldızlı; Gokhan Coral; Furkan Ayaz
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

7.  Repurposing of Tamoxifen Against the Oral Bacteria.

Authors:  Ali Abdul Hussein S Al-Janabi
Journal:  Turk J Pharm Sci       Date:  2021-02-25

8.  Multiresistant Bacteria Isolated from Intestinal Faeces of Farm Animals in Austria.

Authors:  Herbert Galler; Josefa Luxner; Christian Petternel; Franz F Reinthaler; Juliana Habib; Doris Haas; Clemens Kittinger; Peter Pless; Gebhard Feierl; Gernot Zarfel
Journal:  Antibiotics (Basel)       Date:  2021-04-20

9.  Contamination of Retail Meat Samples with Multidrug-Resistant Organisms in Relation to Organic and Conventional Production and Processing: A Cross-Sectional Analysis of Data from the United States National Antimicrobial Resistance Monitoring System, 2012-2017.

Authors:  Gabriel K Innes; Keeve E Nachman; Alison G Abraham; Joan A Casey; Andrew N Patton; Lance B Price; Sara Y Tartof; Meghan F Davis
Journal:  Environ Health Perspect       Date:  2021-05-12       Impact factor: 9.031

10.  Antibacterial mechanism of Cu-bearing 430 ferritic stainless steel.

Authors:  Zhuang Zhang; Xin-Rui Zhang; Tao Jin; Chun-Guang Yang; Yu-Peng Sun; Qi Li; Ke Yang
Journal:  Rare Metals       Date:  2021-06-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.